-
Je něco špatně v tomto záznamu ?
Metabolic Activity of Sulfate-Reducing Bacteria from Rodents with Colitis
J. Kováč, M. Vítězová, I. Kushkevych,
Jazyk angličtina Země Polsko
Typ dokumentu časopisecké články
NLK
Directory of Open Access Journals
od 2015
Free Medical Journals
od 2015
PubMed Central
od 2015
Europe PubMed Central
od 2015
ProQuest Central
od 2015-01-01 do Před 1 rokem
Open Access Digital Library
od 2014-09-25
Open Access Digital Library
od 2015-01-01
Health & Medicine (ProQuest)
od 2015-01-01 do Před 1 rokem
ROAD: Directory of Open Access Scholarly Resources
od 2015
PubMed
30191181
DOI
10.1515/med-2018-0052
Knihovny.cz E-zdroje
- Publikační typ
- časopisecké články MeSH
Sulfate-reducing bacteria (SRB) are anaerobic microorganisms, which use sulfate as an electron acceptor in the process of dissimilatory sulfate reduction. The final metabolic product of these anaerobic microorganisms is hydrogen sulfide, which is known as toxic and can lead to damage to epithelial cells of the large intestine at high concentrations. Different genera of SRB are detected in the large intestine of healthy human and animals, and with diseases like Crohn's disease and ulcerative colitis. SRB isolated from rodents with ulcerative colitis have produced 1.14 (mice) and 1.03 (rats) times more sulfide ions than healthy rodents. The species of Desulfovibrio genus are the most widespread among all SRB in the intestine. The object of our research was to observe and compare the difference of production of sulfide and reduction of sulfate in intestinal SRB isolated from healthy rodents and rodents with ulcerative colitis.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18034214
- 003
- CZ-PrNML
- 005
- 20181217102621.0
- 007
- ta
- 008
- 181008s2018 pl f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1515/med-2018-0052 $2 doi
- 035 __
- $a (PubMed)30191181
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a pl
- 100 1_
- $a Kováč, Jozef $u Department of Experimental Biology (Section of Microbiology), Faculty of Science, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic.
- 245 10
- $a Metabolic Activity of Sulfate-Reducing Bacteria from Rodents with Colitis / $c J. Kováč, M. Vítězová, I. Kushkevych,
- 520 9_
- $a Sulfate-reducing bacteria (SRB) are anaerobic microorganisms, which use sulfate as an electron acceptor in the process of dissimilatory sulfate reduction. The final metabolic product of these anaerobic microorganisms is hydrogen sulfide, which is known as toxic and can lead to damage to epithelial cells of the large intestine at high concentrations. Different genera of SRB are detected in the large intestine of healthy human and animals, and with diseases like Crohn's disease and ulcerative colitis. SRB isolated from rodents with ulcerative colitis have produced 1.14 (mice) and 1.03 (rats) times more sulfide ions than healthy rodents. The species of Desulfovibrio genus are the most widespread among all SRB in the intestine. The object of our research was to observe and compare the difference of production of sulfide and reduction of sulfate in intestinal SRB isolated from healthy rodents and rodents with ulcerative colitis.
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Vítězová, Monika $u Department of Experimental Biology (Section of Microbiology), Faculty of Science, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic. $7 pna2015879848
- 700 1_
- $a Kushkevych, Ivan $u Department of Experimental Biology (Section of Microbiology), Faculty of Science, Masaryk University, Kamenice 753/5, 62500 Brno, Czech Republic. $7 ola2018986853
- 773 0_
- $w MED00196573 $t Open medicine (Warsaw, Poland) $x 2391-5463 $g Roč. 13, č. - (2018), s. 344-349
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/30191181 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20181008 $b ABA008
- 991 __
- $a 20181217102752 $b ABA008
- 999 __
- $a ind $b bmc $g 1341079 $s 1031208
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2018 $b 13 $c - $d 344-349 $e 20180831 $i 2391-5463 $m Open medicine $n Open Med (Wars) $x MED00196573
- LZP __
- $a Pubmed-20181008